Endothelial Nitric Oxide Synthase (NOS3)

Endothelial Nitric Oxide Synthase (NOS3/eNOS)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Endothelial Nitric Oxide Synthase (NOS3)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NOS3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Endothelial Nitric Oxide Synthase (NOS3)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NOS3" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/hepatitis" style="color:#ef9a9a">Hepatitis</a>, <a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">198 edges</a></td>
</tr>
</table>

Pathway Diagram

Endothelial Nitric Oxide Synthase (NOS3/eNOS)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Endothelial Nitric Oxide Synthase (NOS3)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NOS3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Endothelial Nitric Oxide Synthase (NOS3)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NOS3" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/hepatitis" style="color:#ef9a9a">Hepatitis</a>, <a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">198 edges</a></td>
</tr>
</table>

Pathway Diagram

Overview

NOS3 (Endothelial Nitric Oxide Synthase, also called eNOS) is a 1157-amino acid enzyme primarily expressed in vascular endothelial cells where it catalyzes the production of nitric oxide (NO) from L-arginine. NOS3 is a calcium/calmodulin-dependent enzyme that plays critical roles in regulating vascular tone, blood pressure, cerebral blood flow, and blood-brain barrier (BBB) integrity [@katusic2009].

The neurovascular unit, comprising endothelial cells, pericytes, astrocytes, and neurons, depends on proper NOS3 function for maintaining cerebral perfusion and neural homeostasis. Dysregulation of NOS3 contributes to the vascular dysfunction observed in Alzheimer's disease (AD), Parkinson's disease (PD), stroke, and vascular cognitive impairment (VCI) [@van2006][@girouard2006].

Nitric oxide produced by NOS3 acts as a signaling molecule that:

• Relaxes vascular smooth muscle to increase blood flow
• Inhibits platelet adhesion and aggregation
• Protects against atherosclerosis
• Regulates blood-brain barrier function
• Modulates neuroinflammatory responses
• Affects synaptic plasticity and memory formation

Molecular Biology

Structure and Domains

NOS3 is a modular enzyme with distinct functional domains:

• N-terminal oxygenase domain (1-490 aa): Contains binding sites for heme, tetrahydrobiopterin (BH4), and L-arginine substrate
• Calmodulin-binding domain (510-560 aa): Mediates calcium-dependent activation
• C-terminal reductase domain (561-1157 aa): Contains binding sites for FAD, FMN, and NADPH electron donors

• Heme (Fe3+) - required for catalysis
• Tetrahydrobiopterin (BH4) - essential for coupling and preventing uncoupling
• FAD and FMN - electron transfer from NADPH to heme
• Calmodulin - calcium sensor that activates the enzyme

Expression and Localization

NOS3 is primarily expressed in:

• Vascular endothelial cells - lining all blood vessels
• Plasma membrane - caveolae-mediated localization
• Golgi apparatus - perinuclear pool
• Neurons - lower levels, for synaptic plasticity
• Astrocytes - some expression, contributes to neurovascular coupling

• Cerebral cortex microvasculature
• Hippocampal blood vessels
• Choroid plexus
• Meningeal vessels

Regulation

NOS3 activity is regulated at multiple levels:

Normal Function

Vascular Homeostasis

NOS3-derived nitric oxide maintains vascular health through several mechanisms:

Vasodilation: NO diffuses to vascular smooth muscle cells, activating guanylyl cyclase and increasing cGMP, leading to relaxation and increased blood flow. This is the basis for the therapeutic use of nitrates in cardiovascular disease [@katusic2009].

Anti-inflammatory: NO inhibits leukocyte adhesion to endothelial cells by downregulating adhesion molecule expression (VCAM-1, ICAM-1, E-selectin).

Anti-proliferative: NO suppresses vascular smooth muscle cell proliferation, maintaining vessel wall integrity.

Antioxidant: NO can act as an antioxidant, scavenging reactive oxygen species (ROS).

Cerebral Blood Flow Regulation

NOS3 is critical for regulating cerebral blood flow (CBF):

Neurovascular coupling: Neural activity triggers increased CBF through NOS3-mediated vasodilation. This process, called functional hyperemia, ensures adequate oxygen and glucose delivery to active brain regions. Astrocyte endfeet processes sense neuronal activity and signal to endothelial cells via NOS3 [@girouard2006][@iadecola2009].

Autoregulation: NOS3 helps maintain relatively constant CBF despite changes in systemic blood pressure, protecting the brain from hypo- or hypertension.

CO2 reactivity: NOS3 mediates CBF responses to changes in arterial CO2 partial pressure, an important physiological response.

Blood-Brain Barrier Integrity

NOS3 plays a dual role in BBB regulation:

Baseline maintenance: Low-level NO production helps maintain BBB tight junction integrity through cGMP-dependent signaling.

Permeability modulation: Excessive NOS3 activation or uncoupling leads to increased BBB permeability, potentially allowing harmful substances into the brain.

Role in Neurodegenerative Diseases

Alzheimer's Disease

NOS3 dysfunction is intimately linked to AD pathogenesis through multiple mechanisms:

Cerebral hypoperfusion: Reduced NOS3 activity leads to decreased cerebral blood flow, observed in early AD. This chronic hypoperfusion contributes to neuronal dysfunction and may accelerate amyloid pathology [@kim2008][@van2006].

Amyloid-β interaction: Amyloid-β peptides directly impair NOS3 function through several mechanisms:

• Reducing NOS3 phosphorylation at Ser1177
• Increasing NOS3 uncoupling
• Promoting oxidative inactivation of BH4
• Enhancing endothelial cell apoptosis

Neurovascular unit dysfunction: AD affects all components of the neurovascular unit. NOS3 impairment contributes to:

• Blood-brain barrier breakdown
• Reduced amyloid clearance
• Diminished neurovascular coupling
• Cerebral amyloid angiopathy

Parkinson's Disease

NOS3 contributes to PD pathogenesis through vascular and non-vascular mechanisms:

Cerebral hypoperfusion: Reduced NOS3 activity and cerebral blood flow are observed in PD patients, particularly in the substantia nigra and basal ganglia [@wang2006].

Dopaminergic neuron vulnerability: The high metabolic activity of dopaminergic neurons makes them particularly dependent on adequate blood supply. NOS3-mediated dysregulation may contribute to their selective vulnerability.

Neuroinflammation: NOS3 interacts with neuroinflammatory processes in PD. While low-level NO may be protective, excessive production from inducible NOS (iNOS) contributes to dopaminergic toxicity.

L-DOPA response: Some studies suggest NOS3 polymorphisms affect response to L-DOPA therapy in PD patients [@wang2006].

Stroke and Ischemic Injury

NOS3 has complex, time-dependent effects in stroke:

Protective effects: Before and immediately after ischemia, NOS3-derived NO helps maintain cerebral perfusion and protects neurons through antioxidant and anti-apoptotic mechanisms.

Detrimental effects: During reperfusion, NOS3 can contribute to oxidative stress and blood-brain barrier disruption through peroxynitrite formation when NO reacts with superoxide.

Therapeutic window: Timing of NOS3 modulation is critical. NOS3 enhancers given before stroke or very early after onset may be beneficial [@liu2019].

Vascular Cognitive Impairment (VCI)

NOS3 is central to VCI pathogenesis:

Small vessel disease: NOS3 dysfunction contributes to cerebral small vessel disease, including white matter lesions and lacunes, which are major contributors to VCI [@pantoni2010].

Vascular risk factors: Hypertension, diabetes, and hyperlipidemia all impair NOS3 function, creating vascular cognitive vulnerability.

White matter integrity: NOS3-mediated regulation of cerebral blood flow is essential for white matter maintenance. Chronic hypoperfusion leads to white matter damage and cognitive decline [@osullivan2018].

Strategic infarcts: NOS3-related vascular dysfunction may promote strategically placed infarcts that disproportionately affect cognition.

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS): Some studies find altered NOS3 expression in ALS motor cortex and spinal cord, potentially contributing to vascular compromise.

Huntington's Disease (HD): NOS3 polymorphisms may modify age of onset and disease progression in HD.

Multiple Sclerosis (MS): NOS3 dysregulation affects blood-brain barrier integrity and lesion formation in MS.

Therapeutic Approaches

NOS3 Enhancers

Statins: HMG-CoA reductase inhibitors upregulate NOS3 expression and activity, improving endothelial function. Atorvastatin and rosuvastatin have been studied in AD and vascular cognitive impairment.

L-arginine supplementation: Substrate enhancement may boost NO production, though results have been mixed.

BH4 supplementation: Restoring BH4 levels may improve NOS3 coupling, particularly in states of oxidative stress.

Phosphodiesterase inhibitors: Drugs like sildenafil (which increase cGMP) enhance NOS3-mediated signaling downstream of NO production.

NOS3-Targeted Strategies

Gene therapy: Delivering NOS3 genes to enhance endothelial NO production is in development for cardiovascular disease and potentially for neurodegeneration.

Nanoparticle delivery: Targeted nanoparticles could deliver NOS3-activating compounds specifically to cerebral endothelium.

Antioxidants: Protecting NOS3 from oxidative inactivation by scavenging ROS.

Interactions and Signaling Pathways

Protein Interactions

• Caveolin-1 (CAV1): Inhibits NOS3 when bound; displacement by calmodulin activates the enzyme
• Calmodulin (CALM1): Calcium sensor that activates NOS3
• Heat shock protein 90 (HSP90): Facilitates NOS3 signaling
• Akt/PKB: Phosphorylates and activates NOS3 at Ser1177
• AMP-activated protein kinase (AMPK): Activates NOS3
• G-protein coupled receptors: Many activate NOS3 through Akt-dependent pathways

Signaling Pathways

• cGMP/PKG pathway: NO activates soluble guanylyl cyclase, increasing cGMP
• PI3K/Akt pathway: Growth factor signaling to NOS3
• MAPK pathway: Stress-activated signaling affects NOS3
• Estrogen signaling: Estrogen receptors upregulate NOS3 expression

Cross-Links

• [NOS3 Gene](/genes/nos3) - Gene page
• [Nitric Oxide](/entities/nitric-oxide) - Signaling molecule
• [Blood-Brain Barrier](/mechanisms/blood-brain-barrier) - Related pathway
• [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease context
• [Parkinson's Disease](/diseases/parkinsons-disease) - Disease context
• [Cerebral Blood Flow](/mechanisms/cerebral-blood-flow) - Related mechanism
• [Vascular Cognitive Impairment](/diseases/vascular-cognitive-impairment) - Disease context

References

External Links

• [UniProt: Q9UHD5](https://www.uniprot.org/uniprot/Q9UHD5)
• [GeneCards: NOS3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NOS3)
• [NCBI Gene: NOS3](https://www.ncbi.nlm.nih.gov/gene/4846)
• [PDB: 1M9J](https://www.rcsb.org/structure/1M9J) - NOS3 heme domain structure

Pathway Diagram

The following diagram shows the key molecular relationships involving Endothelial Nitric Oxide Synthase (NOS3) discovered through SciDEX knowledge graph analysis: